STOCK TITAN

HIMS insider files Form 144 for 13,749 vested shares, $694K value

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) Form 144 records an insider notice for the proposed sale of 13,749 Class A shares through Fidelity Brokerage Services with an aggregate market value of $694,324.50, approximately tied to the reported outstanding share count of 217,641,958 shares. The proposed sale date is 09/17/2025. The shares were acquired on 09/15/2025 via restricted stock vesting and were paid as compensation. The filing lists prior Class A sales by the same person, Michael Y. Chi, totaling multiple transactions between June and September 2025 with gross proceeds shown per trade.

Positive

  • Timely and detailed disclosure of the proposed sale, acquisition date, and nature of acquisition (restricted stock vesting).
  • Broker and proposed sale date provided, improving transparency for market participants.
  • Prior sales listed for the three-month period by the same insider, showing historical liquidity activity.

Negative

  • None.

Insights

TL;DR: Routine insider sale notice reflecting recently vested shares and prior open-market sales; disclosure appears complete.

The Form 144 documents a proposed sale of 13,749 Class A shares acquired two days earlier by restricted stock vesting and designated as compensation. The transaction is to be executed via a national broker and the filing provides a clear link to prior insider disposals by the same individual across June–September 2025 with material gross proceeds per trade. For investors, this is a standard insider liquidity event rather than an operational disclosure; the filing fulfills Rule 144 notice requirements and lists outstanding shares and per-trade proceeds.

TL;DR: Compliance-focused filing showing timely reporting of vested shares and ongoing insider sales.

The document shows the insider represented no undisclosed material information and supplied dates and transaction nature (restricted stock vesting, compensation). The inclusion of prior sales in the three-month window improves transparency. There are no statements here about plan adoption dates or 10b5-1 instructions, so reliance on a trading plan is not asserted. From a governance perspective the filing meets Form 144 content expectations.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What is being reported in the HIMS Form 144?

The filing reports a proposed sale of 13,749 Class A shares acquired via restricted stock vesting on 09/15/2025 to be sold around 09/17/2025 through Fidelity Brokerage Services.

Who is the seller named in the Form 144 for HIMS?

The seller listed for prior trades is Michael Y. Chi, with multiple Class A share sales reported between June and September 2025.

What was the aggregate market value of the shares proposed for sale?

The aggregate market value reported for the 13,749 shares is $694,324.50.

How many shares outstanding does the filing cite for HIMS?

The filing cites 217,641,958 Class A shares outstanding.

Were these shares purchased or received as compensation?

The shares were acquired on 09/15/2025 by restricted stock vesting and the filing lists the nature of payment as compensation.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

3.80B
204.96M
10.63%
88.99%
33.02%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO